Science Explorer Back to mapMap
Discussion
Nonprofit · Herriman · United States

Cholangiocarcinoma Foundation

cholangiocarcinoma.orgROR OpenAlex
Research works
14
▲ 255% vs 2018-21
Citations
215
15.7 per fractional work
Top-10% rate
11.2%
all institutions 10.0%
Open access
59%
world 40%
International
49%
world 18%
Cholangiocarcinoma Foundation

Not ranked overall: Cholangiocarcinoma Foundation is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Cholangiocarcinoma Foundation work in?

In all years, 79% of research at Cholangiocarcinoma Foundation is in Health Sciences, 14% in Life Sciences. Its largest fields are Medicine (78%), Biochemistry, Genetics and Molecular Biology (13%), Economics, Econometrics and Finance (3%). It does 2.2× the world's share of Health Sciences.

Health Sciences: 11 fractional works · 79.4% of its workMedicine: 11 fractional works · 78.2% of its workSurgery: 5 fractional works · 33.3% of its workOncology: 2 fractional works · 15.7% of its workPulmonary and Respiratory Medicine: 2 fractional works · 12.1% of its workHepatology: 0 fractional works · 3.6% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 3.2% of its workPathology and Forensic Medicine: 0 fractional works · 3.1% of its workRheumatology: 0 fractional works · 2.4% of its workEpidemiology: 0 fractional works · 2.3% of its workPharmacology: 0 fractional works · 0.8% of its workTransplantation: 0 fractional works · 0.8% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 0.6% of its workVeterinary: 0 fractional works · 0.6% of its workSmall Animals: 0 fractional works · 0.6% of its workDentistry: 0 fractional works · 0.4% of its workOral Surgery: 0 fractional works · 0.4% of its workHealth Professions: 0 fractional works · 0.2% of its workPharmacy: 0 fractional works · 0.2% of its workLife Sciences: 2 fractional works · 13.7% of its workBiochemistry, Genetics and Molecular Biology: 2 fractional works · 13.1% of its workCancer Research: 1 fractional works · 6.1% of its workMolecular Biology: 1 fractional works · 3.9% of its workGenetics: 0 fractional works · 3.1% of its workImmunology and Microbiology: 0 fractional works · 0.6% of its workParasitology: 0 fractional works · 0.6% of its workSocial Sciences: 1 fractional works · 3.9% of its workEconomics, Econometrics and Finance: 0 fractional works · 3.4% of its workEconomics and Econometrics: 0 fractional works · 3.4% of its workSocial Sciences: 0 fractional works · 0.5% of its workHealth: 0 fractional works · 0.5% of its workPhysical Sciences: 0 fractional works · 2.9% of its workChemistry: 0 fractional works · 0.8% of its workOrganic Chemistry: 0 fractional works · 0.8% of its workComputer Science: 0 fractional works · 0.8% of its workArtificial Intelligence: 0 fractional works · 0.8% of its workMathematics: 0 fractional works · 0.7% of its workStatistics and Probability: 0 fractional works · 0.7% of its workEnvironmental Science: 0 fractional works · 0.6% of its workEcology: 0 fractional works · 0.6% of its workALL ITS WORKCholangiocarcinomaFoundation14fractional works, all years
Life Sciences14%Physical Sciences3%Health Sciences79%Social Sciences4%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 12 fields, with their numbers
    1. Medicine1178.2%
    2. Veterinary00.6%
    3. Dentistry00.4%
    4. Health Professions00.2%
    1. Biochemistry, Genetics and Molecular Biology213.1%
    2. Immunology and Microbiology00.6%
    1. Economics, Econometrics and Finance03.4%
    2. Social Sciences00.5%
    1. Chemistry00.8%
    2. Computer Science00.8%
    3. Mathematics00.7%
    4. Environmental Science00.6%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 2.90× its world share, 2 worksBiochemistry, Geneti…Computer Science: 0.14× its world share, 0 worksComputer ScienceMathematics: 0.85× its world share, 0 worksMathematicsDentistry: 1.14× its world share, 0 worksDentistryMedicine: 3.99× its world share, 8 worksMedicineEconomics, Econometrics and Finance: 2.10× its world share, 0 worksEconomics, Econometr…Social Sciences: 0.05× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.0×. Every wedge is a field page.

All 7 fields, with their numbers
  1. Medicine3.99×8 works
  2. Biochemistry, Genetics and Molecular Biology2.90×2 works
  3. Economics, Econometrics and Finance2.10×0 works
  4. Dentistry1.14×0 works
  5. Mathematics0.85×0 works
  6. Computer Science0.14×0 works
  7. Social Sciences0.05×0 works

Who are the top researchers at Cholangiocarcinoma Foundation?

Ranked on the quality score, Melinda Bachini and Stacie C. Lindsey lead among researchers whose main affiliation is Cholangiocarcinoma Foundation.

  1. 1 Melinda Bachini United States · #765,919 worldwide 2.9k citations · 41 works
  2. 2 Stacie C. Lindsey United States · #846,260 worldwide 275 citations · 26 works
All ranked researchers at Cholangiocarcinoma Foundation

What are the most cited papers from Cholangiocarcinoma Foundation?

The most cited paper from Cholangiocarcinoma Foundation is "Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology" (Al B. Benson et al., 2021), with 1,068 citations. Next come "Cholangiocarcinoma" (889) and "Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline" (459).

Most cited papers
#PaperReleasedCitations
1 Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology Al B. Benson et al. · Journal of the National Comprehensive Cancer Network May 2021 1,068
2 Cholangiocarcinoma Paul J. Brindley, Melinda Bachini, Sumera Irie Ilyas et al. · Nature Reviews Disease Primers ReviewOpen access 9 Sep 2021 889
3 Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline Rachna T. Shroff, Erin B. Kennedy, Melinda Bachini et al. · Journal of Clinical Oncology 11 Mar 2019 459
4 Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study Do‐Youn Oh et al. · ˜The œLancet. Gastroenterology & hepatology Open access 29 May 2024 297
5 NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023 Al B. Benson et al. · Journal of the National Comprehensive Cancer Network Open access Jul 2023 213
All 84 most cited papers, with filters and sorting

Which research topics does Cholangiocarcinoma Foundation publish most on?

By volume in 2022-now: Cholangiocarcinoma and Gallbladder Cancer Studies, Gallbladder and Bile Duct Disorders, Pancreatic and Hepatic Oncology Research and Cancer Genomics and Diagnostics.

Cholangiocarcinoma and G…3Cholangiocarcinoma and Gallbladder Cancer Studies: 3 fractional worksGallbladder and Bile Duct Disorders: 1 fractional worksPancreatic and Hepatic Oncology Research: 1 fractional worksCancer Genomics and Diagnostics: 1 fractional worksLiver Diseases and Immun…0Liver Diseases and Immunity: 0 fractional worksEthics in Clinical Research: 0 fractional worksFolate and B Vitamins Research: 0 fractional worksEconomic and Financial Impacts of Cancer: 0 fractional worksGastric Cancer Management and Outcomes: 0 fractional worksGenomics and Rare Diseases: 0 fractional works
SurgeryPulmonary and Respiratory MedicineOncologyCancer Research5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cholangiocarcinoma and Gallbladder Cancer Studies Surgery 3 works
  2. 2 Gallbladder and Bile Duct Disorders Pulmonary and Respiratory Medicine 1 works
  3. 3 Pancreatic and Hepatic Oncology Research Oncology 1 works
  4. 4 Cancer Genomics and Diagnostics Cancer Research 1 works
  5. 5 Liver Diseases and Immunity Hepatology 0 works
  6. 6 Ethics in Clinical Research Public Health, Environmental and Occupational Health 0 works
  7. 7 Folate and B Vitamins Research Rheumatology 0 works
  8. 8 Economic and Financial Impacts of Cancer Economics and Econometrics 0 works
  9. 9 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 0 works
  10. 10 Genomics and Rare Diseases Genetics 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available58.6%not open41.4%

World: 40% of research is openly available.

with international co-authors48.9%domestic only51.1%

World: 18% is written across borders.

How has Cholangiocarcinoma Foundation's research output changed?

Output in 2022-2025 was 255% higher than in 2018-2021.

still counting20202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Cholangiocarcinoma Foundation as a percentage of every work published that year, 0.000041% in 2024.

still counting0.000020%0.000040%0.000060%Cholangiocarcinoma Foundation0.000044% in 20252020

Fractional works of Cholangiocarcinoma Foundation over all fractional works that year. How the balance of science has shifted.

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Cholangiocarcinoma Foundation. Posts are plain text and can be reported.